FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories Major ChlorproMAZINE Hydrochloride Tablets Recall

Major ChlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100 Tablets (10x10) blister pac…

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories · La Vergne, TN

Risk level
Class II
Reported by FDA
Oct 15, 2025
Recall ID
D-0010-2026
Check your lot numberHow we source this data

Summary

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalled Major ChlorproMAZINE Hydrochloride Tablets starting Sep 12, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0010-2026 on Oct 15, 2025. Reason: CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit. Status: Ongoing.

Why it was recalled

CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

Product description

Major ChlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100 Tablets (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7130-61, UPC (01)00309047130610

Lot numbers, UPCs & expiration codes

Lots N01954, Exp. Date, 11/30/2025 & N02024, Exp. Date, 02/28/2026

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0010-2026
Classification
Class II
Status
Ongoing
Recall initiated
Sep 12, 2025
FDA report date
Oct 15, 2025
Quantity
1256 blister packs
Recall type
Voluntary: Firm initiated
Recalling firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Original FDA data

Every field from FDA enforcement report D-0010-2026, exactly as published.

Show all FDA fields
City
La Vergne
State
TN
Status
Ongoing
Country
United States
Event ID
97584
Address
341 Mason Rd
Code information
Lots N01954, Exp. Date, 11/30/2025 & N02024, Exp. Date, 02/28/2026
Postal code
37086-3606
Report date
Oct 15, 2025
Product type
Drugs
Recall number
D-0010-2026
Classification
Class II
Recalling firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Product quantity
1256 blister packs
Reason for recall
CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
Voluntary / mandated
Voluntary: Firm initiated
Product description
Major ChlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100 Tablets (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7130-61, UPC (01)00309047130610
Distribution pattern
Nationwide
Recall initiation date
Sep 12, 2025
Initial firm notification
Letter
Center classification date
Oct 7, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0010-2026, published Oct 15, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls